MedPath

Sing to Your Bump

Completed
Conditions
Mild to moderate anxiety and depression during pregnancy.
Mental and Behavioural Disorders
Registration Number
ISRCTN16896708
Lead Sponsor
Goldsmiths, University of London
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
210
Inclusion Criteria

1. Fluent in English
2. 18-45 years old
3.Singleton pregnancy
4. Mild to moderate depression and anxiety

Exclusion Criteria

1. Serious medical disorder, psychosis, bipolar disorder or drug abuse
2. Severe depression or anxiety

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome as of 25/07/2016:<br>Depression is measured using the The Edinburgh Postnatal Depression Scale (EPDS) at baseline (16-24 weeks gestation), 26 weeks gestation, 32 weeks gestation, and 1, 3 and 6 months postnatal.<br><br>Original primary outcomes:<br>1. Depression is measured using the The Edinburgh Postnatal Depression Scale (EPDS) 30 weeks antenatal and 1,3 and 6 months postnatal<br>2. Anxiety is measured using the Peer Relations Assessment Questionnaires-Revised (PRAQ-R) and The State-Trait Anxiety Inventory (STAI) 30 weeks antenatal and 1,3 and 6 months postnatal<br>3. Stress is measured using Parenting Stress Index (PSI-4-SF) 30 weeks antenatal and 1,3 and 6 months postnatal<br>4. Mother Infant bonding is measured using Maternal Antenatal Attachment Scale at 30 weeks antenatal and The Mother-Infant Bonding Scale (MIBS) 1, 3 and 6 months post-natal<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath